Mona Irene Pedersen
Overview
Explore the profile of Mona Irene Pedersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Forde D, Kilvaer T, Pedersen M, Blix E, Urbarova I, Paulsen E, et al.
Front Immunol
. 2025 Jan;
15:1504220.
PMID: 39749327
Introduction: Tumor-infiltrating lymphocytes are both prognostic and predictive biomarkers for immunotherapy response. However, less is known about the survival benefits oftheir subpopulations. Methods: Using machine learning models, we assessed the...
2.
Tylden E, Delgado A, Lukic M, Moi L, Rasmussen Busund L, Pedersen M, et al.
Sci Rep
. 2024 Oct;
14(1):25022.
PMID: 39443510
MicroRNAs are involved in breast cancer development and progression, holding potential as biomarkers and therapeutic targets or tools. The roles of miR-20a-5p, a member of the oncogenic miR-17-92 cluster, remain...
3.
Paulsen E, Andersen S, Rakaee M, Pedersen M, Lombardi A, Pohl M, et al.
Front Oncol
. 2023 May;
13:1157461.
PMID: 37182191
Introduction: Non-small cell lung carcinomas (NSCLC) exhibit different microvessel patterns (MVPs). Basal (BA), diffuse (DA) and papillary (PA) patterns show signs of angiogenesis (new blood vessels), while an alveolar pattern...
4.
Selven H, Rasmussen Busund L, Andersen S, Pedersen M, Lombardi A, Kilvaer T
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900240
Colon cancer is a common malignancy and a major contributor to human morbidity and mortality. In this study, we explore the expression and prognostic impact of IRS-1, IRS-2, RUNx3, and...
5.
Stikbakke E, Wilsgaard T, Haugnes H, Pedersen M, Knutsen T, Stoyten M, et al.
Cancers (Basel)
. 2022 Mar;
14(5).
PMID: 35267449
The role of miR-24-1-5p and its prognostic implications associated with prostate cancer are mainly unknown. In a population-based cohort, the Prostate Cancer Study throughout life (PROCA-life), all men had a...
6.
Nystad M, Sitras V, Nordbakken C, Pedersen M, Acharya G
Acta Obstet Gynecol Scand
. 2018 Jan;
97(5):536-544.
PMID: 29355889
Introduction: Laeverin is a placenta-specific protein that is normally expressed in the plasma membrane of human trophoblasts. In previous studies, we showed higher expression levels of laeverin gene in preeclamptic...
7.
Richardsen E, Andersen S, Al-Saad S, Rakaee M, Nordby Y, Pedersen M, et al.
PLoS One
. 2017 Nov;
12(11):e0186852.
PMID: 29141018
The tumor proliferation index marker Ki-67 is strongly associated with tumor cell proliferation, growth and progression, and is widely used in routine clinicopathological investigation. Prostate cancer is a complex multifaceted...
8.
Johannessen C, Moi L, Kiselev Y, Pedersen M, Dalen S, Braaten T, et al.
PLoS One
. 2017 Oct;
12(10):e0186658.
PMID: 29073169
MicroRNAs (miRNAs) are small non-coding RNAs that function as post-transcriptional regulators of gene expression and are dysregulated in cancer. Studies of miRNAs to explore their potential as diagnostic and prognostic...
9.
Stenvold H, Donnem T, Andersen S, Al-Saad S, Valkov A, Pedersen M, et al.
BMC Clin Pathol
. 2014 Feb;
14(1):9.
PMID: 24524655
Background: MicroRNA (miR)-21 has been revealed as an oncogene in cancer development, and is one of the miRNAs closely connected to angiogenesis. We aimed to explore the impact of miR-21...